Published Papers & Misc - FUJII Yasuhisa

101. Ishii A, Yokoyama M, Tsuji H, Fujii Y, Tamaoka A. Pembrolizumab treatment of metastatic urothelial cancer without exacerbating myasthenia gravis eNeurologicalSci. 2020;

102. Fukushima H, Fujii Y. Editorial Comment to Does asymptomatic bacteriuria affect the response to intravesical bacillus Calmette-Guerin? Int J Urol. 2020;

103. Fukushima H, Saito K, Yasuda Y, Tanaka H, Patil D, Cotta BH, Patel SH, Master VA, Derweesh IH, Fujii Y. Female Gender Predicts Favorable Prognosis in Patients With Non-metastatic Clear Cell Renal Cell Carcinoma Undergoing Curative Surgery: Results From the International Marker Consortium for Renal Cancer (INMARC) Clin Genitourin Cancer. 2020;

104. Fukushima H, Moriyama S, Waseda Y, Fukuda S, Uehara S, Tanaka H, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Significance of Bladder Neck Involvement in Risk Substratification of Intermediate-Risk Non-muscle-invasive Bladder Cancer Eur Urol Focus. 2020;

105. Fukushima H, Inoue M, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Incidence and risk factors of hypertension following partial nephrectomy in patients with renal tumors: a cross-sectional study of postoperative home blood pressure and antihypertensive medications Clin Genitourin Cancer. 2020;

106. Fukushima H, Kijima T, Fukuda S, Moriyama S, Uehara S, Yasuda Y, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Saito K, Matsubara N, Numao N, Sakai Y, Yuasa T, Masuda H, Yonese J, Kageyama Y, Fujii Y. Impact of radiotherapy to the primary tumor on the efficacy of pembrolizumab for patients with advanced urothelial cancer: a preliminary study Cancer Med. 2020; 9: 8355-8363. doi: 10.1002/cam4.3445. 2020;

107. Fukushima H, Fukuda S, Moriyama S, Uehara S, Yasuda Y, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Fujii Y. Impact of sarcopenia on the efficacy of pembrolizumab in patients with advanced urothelial carcinoma: a preliminary report Anticancer Drugs. 2020; 31: 866-871. doi: 10.1097/CAD.0000000000000982.. 2020;

108. Tanaka H, Fujii Y. Editorial Comment to Lymph node dissection for bladder cancer: Current standards and the latest evidence Int J Urol. 2020. doi: 10.1111/iju.14419. 2020;

109. Tanaka H, Fujii Y. Editorial Comment from Dr Tanaka and Dr Fujii to Oncological outcomes and recurrence patterns following laparoscopic radical cystectomy for bladder cancer: A Japanese multicenter cohort Int J Urol. 2020. doi: 10.1111/iju.14194. 2020;

110. Tanaka H, Fukushima H, Kijima T, Nakamura Y, Yajima S, Uehara S, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. Feasibility and outcomes of selective tetramodal bladder-preservation therapy in elderly patients with muscle-invasive bladder cancer Int J Urol. 2020; 27: 236-243. *Equal contribution. 2020;

111. Matsuoka Y, Uehara S, Yoshida S, Tanaka H, Yokoyama M, Fujii Y. Three-dimensional analysis of systematic biopsy-derived prostate cancer upgrading over targeted biopsy Int J Urol. 2020 Oct 27. doi: 10.1111/iju.14410. 2020;

112. Matsuoka Y, Uehara S, Yoshida S, Tanaka H, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Saito K, Fujii Y. Value of extra-target prostate biopsy for the detection of magnetic resonance imaging-missed adverse pathology according to the Prostate Imaging Reporting and Data System scores Spatial analysis using magnetic resonance-ultrasound fusion images. Int J Urol. 2020; 27: 760-766. 2020;

113. Toshiki Kijima, Hajime Tanaka, Sho Uehara, Soichiro Yoshida, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara, Yasuhisa Fujii. Clinical Outcomes of Patients With Histologic Variants of Urothelial Carcinoma Treated With Selective Tetramodal Bladder-preservation Therapy Incorporating Consolidative Partial Cystectomy 2019.12;

114. SoichiroYoshida, TaroTakahara, Chikako Ishii, Yuki Arita, Yuma Waseda, Toshiki Kijima, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Yasuhisa Fujii. METastasis Reporting and Data System for Prostate Cancer as a Prognostic Imaging Marker in Castration-resistant Prostate Cancer 2019.12;

115. HiroshiFukushima, KazutakaSaito, YosukeYasuda, HajimeTanaka, DattatrayaPatil, Brittney H.Cotta, Sunil H.Patel, Viraj A.Master, Ithaar H.Derweesh, YasuhisaFujii. Female sex predicts favorable prognosis in non-metastatic clear cell renal cell carcinoma patients undergoing curative surgery: results from the International Marker Consortium for Renal Cancer (INMARC) 2019.11;

116. Yuki Arita, Taro Takahara, Soichiro Yoshida, Thomas C Kwee, Shugo Yajima, Chikako Ishii, Ryota Ishii, Shigeo Okuda, Masahiro Jinzaki, Yasuhisa Fujii. Quantitative Assessment of Bone Metastasis in Prostate Cancer Using Synthetic Magnetic Resonance Imaging. Invest Radiol. 2019.10; 54 (10): 638-644. ( PubMed, DOI )

117. Soichiro Yoshida, Taro Takahara, Yuki Arita, Chikako Ishii, Yusuke Uchida, Keiko Nakagawa, Kazuma Toda, Tsuyoshi Sakamoto, Toshiki Kijima, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Ryoichi Yoshimura, Yasuhisa Fujii. Progressive Site-Directed Therapy for Castration-Resistant Prostate Cancer: Localization of the Progressive Site as a Prognostic Factor. Int. J. Radiat. Oncol. Biol. Phys.. 2019.10; 105 (2): 376-381. ( PubMed, DOI )

118. Masahiro Toide, Minato Yokoyama, Motohiro Fujiwara, Toshiki Kijima, Kazutaka Saito, Yasuhisa Fujii. Renal function after bladder-preserving therapy for patients with muscle-invasive bladder cancer: Results of selective bladder-preserving tetramodality therapy consisting of maximal transurethral resection, induction chemoradiotherapy and partial cystectomy. Int. J. Urol.. 2019.10; 26 (10): 1010-1012. ( PubMed, DOI )

119. Hiroshi Fukushima, Yasuhisa Fujii. Editorial Comment to Does asymptomatic bacteriuria affect the response to intravesical bacillus Calmette-Guérin? Int. J. Urol.. 2019.10; ( PubMed, DOI )

120. Yuma Waseda, Shuichiro Kobayashi, Eiichiro Kanda, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Yasuhisa Fujii. Impact of Bladder Neck Involvement on Recurrence in Patients With Non-muscle-invasive Bladder Cancer: An Analysis Based on a Time-dependent Model. Clin Genitourin Cancer. 2019.10; ( PubMed, DOI )